A carregar...
Activation of EGFR by proteasome inhibition requires HB-EGF in pancreatic cancer cells
Resistance to drug treatments underlies the high lethality of pancreatic ductal adenocarcinoma (PDA). We and others have recently identified that proteasome inhibition is a promising therapeutic option in this highly refractory disease. The pleiotropic effects of proteasome inhibition include the ac...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2010
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3134242/ https://ncbi.nlm.nih.gov/pubmed/20208558 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/onc.2010.52 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|